Concepts represent early planning stages for program announcements, requests for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.
NB: Council approval does not guarantee that a concept will become an initiative.
Table of Contents
Fiscal Year 2019 Concepts
- Sexually Transmitted Infections Cooperative Research Centers: Vaccine Development
- Impact of Initial Influenza Exposure on Immunity in Infants
- Elucidating the Functional Roles of Non-Coding RNAs in Viral Infectious Diseases
- Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development
Fiscal Year 2019 Small Business Innovation Research (SBIR) Contract Solicitation Topics
- Development of Point-of-Care Assays to Quantify Anti-Tuberculosis Antibiotics in Blood
- Mobile Health Point-of-Care Diagnostics
- Point-of-Care Diagnostic for Gonorrhea and Determination of Antimicrobial Susceptibility
Sexually Transmitted Infections Cooperative Research Centers: Vaccine Development
For the published request for applications, see the March 15, 2018 Guide announcement, Sexually Transmitted Infections (STI) Cooperative Research Centers (CRC): Vaccine Development (U19 Clinical Trial Not Allowed).
Impact of Initial Influenza Exposure on Immunity in Infants
For the published request for applications, see the April 5, 2018 Guide announcement, Impact of Initial Influenza Exposure on Immunity in Infants (U01 Clinical Trial Not Allowed).
Elucidating the Functional Roles of Non-Coding RNAs in Viral Infectious Diseases
For the published request for applications, see the June 28, 2018 Guide announcement, Elucidating the Functional Roles of Non-Coding RNAs in Viral Infectious Diseases (R21, Clinical Trial Not Allowed).
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development
For the published program announcements, see the March 28, 2018 Guide announcements, Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed) and Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R01 Clinical Trial Not Allowed).
Development of Point-of-Care Assays to Quantify Anti-Tuberculosis Antibiotics in Blood
For the published request for proposals, see the July 18, 2018 Solicitation of NIH and CDC for Small Business Innovation Research (SBIR) Contract Proposals (PHS 2019-1).
Mobile Health Point-of-Care Diagnostics
For the published request for proposals, see the July 18, 2018 Solicitation of NIH and CDC for Small Business Innovation Research (SBIR) Contract Proposals (PHS 2019-1).
Point-of-Care Diagnostic for Gonorrhea and Determination of Antimicrobial Susceptibility
For the published request for proposals, see the July 18, 2018 Solicitation of NIH and CDC for Small Business Innovation Research (SBIR) Contract Proposals (PHS 2019-1).